BrainLAB's ExacTrac X-ray 6D technology gains reimbursement

BrainLAB announced this week that users of their ExacTrac X-Ray 6D technology can now be reimbursed through a new HCPCS code.
   
The Centers for Medicare and Medicaid (CMS) recognized that Stereoscopic kV X-ray imaging qualifies as a new technology eligible for payment under the hospital outpatient prospective payment system. CMS established a new HCPCS code - C9722 Stereoscopic kV X-ray imaging with infrared tracking for localization of target volume to describe the procedure. HCPCS code C9722 Stereoscopic kV X-ray imaging has been assigned to New Technology APC 1502 with a payment of $75 per treatment fraction, effective Jan. 1, 2005, BrainLAB said.
   
ExacTrac X-Ray 6D, an automated image-guided radiation therapy system, is installed in more than 60 sites around the world. It utilizes high-resolution x-rays to pinpoint internal tumor sites, robotically corrects patient set-up errors and tracks any patient movement throughout the treatment. Two kV x-ray units recessed into the floor and two ceiling-mounted, amorphous silicon, flat-panel detectors enable imaging of internal structures or implanted markers for accurate set-up of the target volume to within 2-mm of the planned isocenter position.
   
ExacTrac X-Ray 6D overcomes the limitations of conventional skin markings traditionally used for patient positioning, BrainLAB said. Prior to patient set-up, the x-ray imaging module calculates any variation between the current and planned target position.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.